Discussion about this post

User's avatar
James Cou's avatar

Is the report from STAT news the latest: ACHV CEO expects FDA approval mid-2026

https://www.statnews.com/2025/04/30/new-stop-smoking-drug-achieve-life-sciences-seeks-fda-approval-for-chantix-competitor/

Expand full comment
Gus's avatar

Interesting! I believe you have a logical argument in this article. What are your thoughts on any risks involved in completing the final phase of the trials, specifically the data from 100 patients over a year? Do you foresee any risks?

Expand full comment
5 more comments...

No posts